期刊文献+

HER-2/neu对雌激素依赖性子宫内膜癌细胞信号通路(MAPK/ERK,PI3K/Akt)调控的研究 被引量:2

Regulating effect of HER-2/neu gene in endometrial cancer cells of estrogen dependent MAPK/ERK,PI3K/Akt signal pathway
暂未订购
导出
摘要 目的:利用HER-2/neu转染前后的Ishikawa细胞株,探讨HER-2/neu对雌激素依赖性子宫内膜癌细胞信号通路(MAPK/ERK、PI3K/Akt)的调控作用。方法:表皮生长因子(endothelial growth factor)处理HER-2/neu转染前后的Ishikawa细胞株,Western-blot检测转染前后细胞COX-2、t-Akt及p-Akt蛋白、t-ERK及p-ERK表达,ELISA方法检测细胞培养上清液中雌二醇的含量。用PI3K/Akt的抑制剂LY294002及MAPK/ERK的抑制剂PD98059抑制信号通路,以不同浓度作用相同时间和以相同浓度分别作用不同时间后,检测COX-2及雌二醇表达水平。结果:转染HER-2/neu的Ishikawa细胞株COX-2蛋白、p-Akt蛋白、p-ERK及细胞上清液中的雌二醇的含量均高于未转染的Ishikawa细胞株(P<0.05)。应用抑制剂分别抑制上述两种通路,转染后细胞株中COX-2的表达水平低于转染前Ishikawa细胞株,同时转染组细胞上清液中雌二醇的含量较未转染组下降明显,降幅更大。随抑制剂浓度的增加及作用时间的延长,两组细胞COX-2及雌二醇的表达均逐渐减少,且抑制作用与浓度及作用时间呈负相关关系。结论:子宫内膜癌Ishikawa细胞株HER-2/neu基因表达的增强进一步引起COX-2、E2表达的增加,可能是通过对信号通路MAPK/ERK、PI3K/Akt的调控而实现的。 Objective :To use HER -2/neu transfected Ishikawa cell line before and after, HER -2/neu estrogen - dependent endometrial cancer cell signaling pathways ( MAPK/ERK, PI3 K/Akt ) regulation. Methods: Epidermal growth factor HER -2/neu transfected Ishikawa cell line before and after, Western -blot transfected cells before and after the expression of COX - 2, t - Akt and p - Akt protein, t - ERK and p - ERK, ELISA method for the detection of cell culture supernatants of estradiol contents. PI3K/Akt inhibitor LY294002 and MAPK/ERK inhibitor PD98059 inhibited signaling pathways, with the same concentration at different time and different concentration to detec COX -2 and estradiol levels. Results: The HER - 2/neu transfected Ishikawa cell line COX - 2 protein, protein p - Akt ; p - ERK and cell supernatant in estradiol content were higher than the normal Ishikawa cell line ( P 〈 0.05 ). Inhibitor in- hibits two pathways, transfected cells the expression level of COX -2 in transfected Ishikawa cell line than before, at the same time E2 in the transfeeted group was compared with non transfected group decreased obviously. With the increase of the concentration and action time, two groups of cells COX - 2 and estradiol expression were gradually decreased, and the inhibitory action and concentration and action time were negatively related. Conclusion: Endometrial carcinoma cell line Ishikawa HER -2/neu enhanced gene expression induced by COX -2,increase the expression of E2.
出处 《现代肿瘤医学》 CAS 2013年第2期242-247,共6页 Journal of Modern Oncology
基金 辽宁省自然科学基金资助项目(编号:20102266) "百千万人才工程"百人层次项目(编号:2010921071) 辽宁省教育厅科研项目(编号:2010642)
关键词 子宫内膜癌 HER-2 neu(c-erbB-2) 细胞外信号调节激酶 磷脂酰肌醇3-激酶 信号通道 雌激素 endometrial carcinoma HER - 2/neu ( c - erbB - 2 ) extracellular signal regulated kinase phosphatidylinositol 3 - kinase signal pathway estrogen
  • 相关文献

参考文献17

  • 1Simeone AM,Li Y J,Broemeling LD. Cyclooxygenase-2 is essential for HER2/neu tosuppress N-(4-hydroxyphenyl) retinamide apoptotic effects in breast cancer cells[J].Cancer Research,2004,(04):1224-1228.
  • 2Wang SC,Lien HC,Xia W. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2[J].Cancer Cells,2004,(03):251-261.
  • 3Tiseo M,Loprevite M,Ardizzoni A. Epidermal growth factor receptor inhibitors:a new prospective in the treatment of lung cancer[J].Current Medicinal Chemistry Anti-Cancer Agents,2004,(02):139-148.
  • 4Riese DJ,Stem DF. Specificity within the EGF family/ErBb receptor family signaling network[J].Bioessays,1998,(01):41-48.doi:10.1002/(SICI)1521-1878(199801)20:1&lt;41::AID-BIES7&gt;3.0.CO;2-V.
  • 5Marmor MD,Skaria KB,Yarden Y. Signal transduction and oncogenesis by ErbB /HER receptors[J].International Journal of Radiation Oncology,Biology,Physics,2004,(03):903-913.
  • 6Tsutsui S,Ohno S,Murakami S. Prognostic value of the combination of epidermal growth factor receptor and cerbB2 in breast cancer[J].Surgery,2003,(02):219-221.doi:10.1067/msy.2003.32.
  • 7Longva KE,Pedersen NM,Haslek C. Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2[J].International Journal of Cancer,2005,(03):359-367.
  • 8Sakai K,Yokote H,Murofushi K. Pertuzumab,a novel HER dimerization inhibitor,inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway[J].Cancer Science,2007,(09):1498-1503.
  • 9Johnson GL,Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK,JNK,and p38 protein kinases[J].Science,2002,(5600):1911-1912.
  • 10Coulombe P,Meloche S. A typical mitogen-activated proteinkinases:Structure,regulation and functions[J].Biochimica Et Biophysica Acta,2007,(08):1376-1387.

二级参考文献22

  • 1万芳,钟刚,何福仙,陈敏,关艳梅.ERK/MAPK信号通路激活与乳腺癌细胞浸润性生长的关系[J].医学研究生学报,2004,17(6):490-492. 被引量:17
  • 2郭瑞霞,魏丽惠,王建六,孙蓬明,孙秀丽.17β-雌二醇对子宫内膜癌细胞磷脂酰肌醇3激酶/蛋白激酶B信号传导通路的激活作用[J].中华妇产科杂志,2004,39(7):469-473. 被引量:37
  • 3Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A,2001,98:10983-10985.
  • 4Troussard AA, Mawji NM, Ong C, et al. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem,2003,278:22374-22378.
  • 5Yuan ZQ, Sun M, Feldman RI, et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.Oncogene,2000,19:2324-2330.
  • 6Shayesteh L, Lu Y, Kuo WL, et al. PIK3CA is implicated as an oncogene in ovarian cancer.Nat Genet,1999,21:99-102.
  • 7Ma YY, Wei SJ, Lin YC, et al.PIK3CA as an oncogene in cervical cancer.Oncogene,2000,19:2739-2744.
  • 8Schondorf T, Gohring UJ, Roth G, et al.Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients.Eur J Clin Invest,2003,33:256-260.
  • 9Kurose K, Zhou XP, Araki T, et al.Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.Am J Pathol,2001,158:2097-2106.
  • 10Yuan ZQ, Feldman RI, Sussman GE, et al. AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance.J Biol Chem,2003,278:23432-23440.

共引文献39

同被引文献20

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部